A New Signal in Photonics, a Valuation Problem in MedTech, and an AI Power Stock Still Running

One small-cap hardware name just gave the market a stronger commercial signal and may have more room if orders keep building. A medical-device rebound looks less convincing once you get into the numbers, while an AI power winner is still trending higher but now demands tighter risk control. We’ll show you where a starter position makes sense, where patience matters, and where momentum is still in charge.

For years, America’s top banks have quietly generated outsized profits — while everyday savers earn next to nothing.

Now, an income strategist points to a little-known investment with significantly higher long-term return potential — and says it may now be within reach for regular investors.

Click here to learn how it works — and decide if it fits your strategy.

Futures are moving higher after Trump extended the Iran ceasefire, giving markets another excuse to lean back into risk. The path still looks choppy, but for now traders are treating the latest Middle East headline as more de-escalation than danger.

Elite Trade Club now offers text alerts — so you get trending stocks and market-moving news sent straight to your phone before the bell.

Email’s great. Texts are faster.

👉 Click here to get our pre-market report to your cell for free!

You’ll be first in line when the market starts moving.

Earnings (Premarket):
• GE Vernova Inc. [GEV]
• Philip Morris International Inc [PM]
• AT&T Inc. [T]
• Boeing Company (The) [BA]
• Vertiv Holdings, LLC [VRT]
• CME Group Inc. [CME]

Earnings (Aftermarket):
• Tesla, Inc. [TSLA]
• Lam Research Corporation [LRCX]
• International Business Machines Corporation [IBM]
• Texas Instruments Incorporated [TXN]

Economic Reports:
• None scheduled

That is the kind of contrast worth paying attention to.

A top executive team at a major aircraft lessor just exercised a large block of options without selling, while a biotech director and affiliated fund sold about $2.47 million across two sessions. Those are very different signals. One points to continued ownership. The other points to cashing out while the stock is sitting at levels insiders were willing to sell into.

Every day, insiders and institutions move millions before the market catches on. Elite Trade Club Insider gives you the data they don’t want you to see.

A subscription gets you:

POET Technologies Inc. (NASDAQ: POET) is moving like a small-cap name that just gave investors a missing piece of the story. The stock jumped more than 20% premarket after management signaled a stronger order roadmap for its photonics components and, more importantly, confirmed for the first time a business relationship with Marvell. That matters because Marvell sits close to some of the biggest AI infrastructure buildouts in the market.

The company’s CFO said orders this year should come in far above the earlier $5 million optical-engine purchase order disclosed last October.

He also pointed to ongoing discussions with major manufacturing partners and existing customers like Foxconn and Luxshare. For a company with a market cap around $1.57 billion, those details go a long way because they shift the conversation from speculation to actual commercial traction.

The catch is that this remains an early-stage story with a hot chart. POET shares are already up roughly 40% in two days and 62% year to date, so enthusiasm is running ahead of fully visible revenue. The opportunity is real, but so is the risk of sharp swings if investors get ahead of the order flow.

My Take For You: This is stronger than a rumor-driven pop because management finally gave the market a concrete commercial signal. Still, small-cap AI hardware names can overshoot fast when sentiment flips this hard.

My Verdict: Start small if you are comfortable with volatility and want speculative exposure to photonics demand. The risk is that order timing disappoints after the market has already priced in rapid acceleration.

Teleflex Inc. (NYSE: TFX) is getting some renewed attention after naming Andrew Krakauer as its next board chairman, while two current directors prepare to step down. On its own, that is not a major catalyst.

But in a stock that has rallied 18.4% in 30 days and 21.2% in 90 days after a long weak stretch, leadership changes can push investors to revisit whether the story is finally improving.

The valuation argument is where things get complicated. One fair-value view puts the stock near $129.25, only modestly above the recent $124.75 close, while analysts are not far above that either.

At the same time, Teleflex trades at roughly 95x earnings, well above the broader medical equipment industry and even above its peer group. That leaves very little room for operational slips, especially with integration work still ahead and ongoing weakness in products like UroLift.

So while the stock may look discounted on some long-term assumptions, the multiple says investors are already paying up for a recovery that has not fully shown up yet. That makes this less of a simple value call and more of an execution story.

My Take For You: The board refresh may help confidence, but the stock still needs cleaner evidence of margin and product improvement before the valuation case feels comfortable. This is a story to verify, not assume.

My Verdict: Keep this on watch rather than chasing the rebound. The risk is that rich valuation and uneven execution turn a decent recovery setup into another false start.

When the SpaceX IPO hits, trillions of dollars inside the financial system will move. Fund managers liquidate. Institutions rebalance. Wall Street reshuffles for the payday of a decade.

Your retirement sits inside that machinery. You don't get a vote on which direction it moves.

Physical gold held outside the banking system is different. No fund manager can touch it. No IPO frenzy reaches it.

A free 2026 Gold Guide explains how to move a portion of your retirement outside the system — tax-free, penalty-free, in days.

Takes 30 seconds to request.

[Get the free Gold Guide]

*America's Gold Company does not provide investment, legal, retirement planning, or tax advice. Individuals should consult with their investment, legal or tax professionals for such services.

Vicor Corp. (NASDAQ: VICR) is acting like a stock the market has decided belongs in the AI infrastructure group. Shares were up nearly 6% premarket after a big run that has already taken the stock up more than 425% over the past year, and the latest push came after Roth Capital raised its price target to $245 and kept a Buy rating tied to AI demand and stronger factory utilization.

The numbers explain why momentum traders keep showing up. Vicor has gross margin above 57%, profit margin above 26%, a light debt load, and a current ratio near 9, which gives it real flexibility even at a premium valuation.

The stock’s move from roughly $142 in late March to the $240-$250 zone now also tells you the market believes AI-related power solutions are becoming a meaningful growth driver.

The caution flag is insider selling. CEO Patrizio Vinciarelli has sold multiple blocks of stock during the rally, including 40,000 shares around $222, though he still controls roughly 9 million shares. That does not kill the story, but it does argue for tighter discipline after a run this extended.

My Take For You: Vicor looks like a real AI power play, not just a sympathy runner, and the margins back that up. But after this kind of move, discipline matters more than enthusiasm.

My Verdict: Own it only if you are willing to sit through sharp pullbacks because the trend is still working. The risk is that insider selling and rich valuation trigger a hard reset if the next results are not strong enough.

York is climbing because this stock still has fresh-issue momentum, and the company just added another fuel source with a new satellite contract and a high-visibility NYSE appearance. The stock has nearly doubled from the high teens to the low 40s in less than a month, so traders clearly see this as a live growth story, not a sleepy aerospace name.

The risk is simple: the business is still not profitable, and at this stage the stock is being driven more by contract headlines and momentum than by earnings power.

MSTR is up because Bitcoin is up, and that is still the whole ballgame here. Bitcoin pushing above $78,000 gives traders a reason to pile back into crypto-linked equities, and Strategy remains one of the most direct high-beta ways to play that move.

The stock is still down more than 50% over the past year, which tells you how violent this trade can get when crypto turns the other way. But when Bitcoin runs, Strategy usually runs harder.

Calix is lower even after posting a solid quarter, and that creates a cleaner setup than the price action suggests. The company beat on both lines with $0.40 EPS versus $0.38 expected and $280 million in revenue versus $277.5 million, while also pointing to 15% to 20% annual growth. That is a good report by any normal standard.

The market is likely nitpicking margins, surcharges, and memory-cost pressure after a strong run. But the core story still looks intact: record revenue, new customer wins, strong liquidity, and platform momentum.

Capital gains taxes can take a bigger bite out of your profits than expected.

Fortunately, some deductions may help reduce the impact — including:

Because rules and eligibility vary, many investors turn to fiduciary financial advisors for guidance.

[Find an Advisor Match]

That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.

Best Regards,

— Adam Garcia
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.